Intrinsa, a female testosterone patch by Proctor & Gamble, showed promising results in boosting the enjoyment of sex in post-menopausal women, but preexisting concerns about the cancer risk of hormone therapies means U.S. women won’t be getting an equivalent Viagra anytime in the near future.